Andrea Necchi

59PUBLICATIONS
288CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Oct 25, 2026
Neoadjuvant nivolumab with or without visugromab in muscle-invasive bladder cancer: the phase 2a GDFATHER-NEO trial.

|Sep 16, 2026
Immunohistochemical stratification of bladder small cell carcinoma reveals two major phenotypes with distinct therapeutic biomarker profiles.

|Aug 05, 2026
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.

|May 31, 2026
Neoadjuvant Sacituzumab Govitecan in Patients With Muscle-Invasive Bladder Cancer: Primary Results of the SURE-01 Trial.

|May 14, 2026
Genomics of MTAP Loss in >500,000 Solid Tumor Specimens Profiled Using Comprehensive Genomic Profiling Platforms.

|Apr 01, 2026
Integrating China's Oncology Innovations into the Global Landscape: A Strategic Blueprint for Precision, Partnership, and Purpose.

Xudong Ni, Tingwei Zhang, Andrea Necchi

Pageof 10

Frequent Collaborators

15 joint publications

Phillip E Spiess

8 joint publications

Filippo Pederzoli

7 joint publications

Petros Grivas

7 joint publications

Ashish M Kamat